Recruiting Pulmonary Hypertension Studies in Memphis
About Pulmonary Hypertension Clinical Trials in Memphis
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 11 pulmonary hypertension clinical trials recruiting participants in Memphis, TN. These studies are seeking a combined 2,084 participants. Research is being sponsored by St. Jude Children's Research Hospital, Daiichi Sankyo, AVM Biotechnology Inc and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Memphis — FAQ
Are there pulmonary hypertension clinical trials in Memphis?
Yes, there are 11 pulmonary hypertension clinical trials currently recruiting in Memphis, TN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Memphis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Memphis research site will contact you about next steps.
Are clinical trials in Memphis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Memphis studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 11 active trials in Memphis are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated July 19, 2026 from ClinicalTrials.gov